SomnoMed Limited (FRA:RJV)

Market Cap	90.19M
Revenue (ttm)	62.24M
Net Income (ttm)	-1.93M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	54.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	110
Open	0.4380
Previous Close	0.4260
Day's Range	0.4380 - 0.4400
52-Week Range	0.2200 - 0.5000
Beta	n/a
RSI	38.15
Earnings Date	Feb 19, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper te...

• Industry: Dental Equipment and Supplies
• Founded: 1987
• Employees: 300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJV

Financial Performance

In 2025, SomnoMed's revenue was 111.49 million, an increase of 21.65% compared to the previous year's 91.65 million. Losses were -3.46 million, -71.77% less than in 2024.

Financial numbers in AUD